“…A GATA-2-occupied Gata2 intronic enhancer (+9.5) containing an E-box-8 bp spacer-AGATAA composite element (E-box-GATA element) is required for hematopoietic stem cell (HSC) emergence from hemogenic endothelium in the mouse embryo (Gao et al, 2013). A GATA-2-occupied enhancer 77 kb upstream of Gata2 (-77), which contains several GATA motifs (Grass et al, 2006), confers myelo-erythroid progenitor differentiation potential, without impacting HSC emergence (Johnson et al, 2015). Insufficient GATA-2 levels/activity resulting from GATA2 coding or +9.5 enhancer mutations underlie hematologic diseases including primary immunodeficiencies that frequently progress to myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) (Dickinson et al, 2011; Hahn et al, 2011; Hsu et al, 2011; Ostergaard et al, 2011) and pediatric MDS/AML independent of immunodeficiency (Wlodarski et al, 2016).…”